Board Member

Margaret (Peggy) Hamburg

Margaret (Peggy) Hamburg

Former US FDA Commissioner; Former Foreign Secretary, National Academy of Medicine

Margaret (Peggy) Hamburg is an internationally recognized leader in science, medicine and public health. She recently completed her term as Foreign Secretary of the National Academy of Medicine, where she served as senior advisor on international matters and liaison with other Academies of Medicine and Science around the world. She continues to represent the National Academies of Science, Engineering and Medicine on the steering committee of the InterAcademy Partnership for Science, Health and Policy, the organization that represents Academies of Science and Medicine around the world. Hamburg is also past Chair/President of the American Association for the Advancement of Science (AAAS), the world’s largest scientific membership organization.

Hamburg was the twenty-first commissioner of the U.S. Food and Drug Administration, where she was known for advancing regulatory science, modernizing regulatory pathways, and globalizing the agency. Before this, she was founding vice president and senior scientist at the Nuclear Threat Initiative, a foundation dedicated to reducing nuclear, chemical, and biological threats. Other past positions include assistant secretary of health and human services for planning and evaluation, health commissioner for New York City, and assistant director of the National Institute of Allergy and Infectious Diseases.

Hamburg is a graduate of Harvard College and Harvard Medical School and is board-certified in internal medicine. She currently chairs the Harvard Medical School board of fellows and serves on numerous other nonprofit boards and advisory councils, as well as on the board of a biotechnology company.

Top Stories on CFR

China

Economics

The consequences of the COVID-19 pandemic and the rise of China have prompted renewed debate about the U.S. government’s role in shaping the economy.

United States

Progress on President Biden’s climate agenda will slow with a split Congress. But with federal efforts dulled, state-level action could supply added momentum.